The Women’s World Cup is in the limelight and it’s an important reminder of the prevention of and recovery from ACL tears. A sports medicine expert discusses this injury and why female soccer players are at risk.
A cancer immunotherapy research group at Baylor College of Medicine has secured Investigational New Drug regulatory clearance through the FDA to perform phase I clinical studies in newly-diagnosed adult patients with glioblastoma.
A potentially disease-modifying therapy for osteoarthritis has reached a key milestone now that a U.S. patent has been issued for FX201, a gene-therapy product candidate based on work led by Baylor researchers.
Researchers have determined a unique fraction of the genome that scientists should focus on. Their report, which provides a “treasure map” to accelerate research in epigenetics and human disease, was published today in Genome Biology.
Baylor College of Medicine will host a community conference and resource fair for the Amarillo area to provide an educational seminar and support materials for parents of children with autism and developmental disabilities.